MENU

ILMN Stock Illumina (ILMN, $100.11) Stochastic Oscillator left the overbought zone on August 15, 2025

A.I.dvisor
at Tickeron.com
Loading...
ILMN - Illumina
Stochastic signal
Bearish Trend
Odds of DOWN Trend
Tickeron
Stochastic signal
Price: $100.11
Daily change: +$0.02 (+0.02%)
Daily volume: 1.5M
Capitalization: $15.8B
Industry: Medical Specialties
This is a signal that ILMN's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position. A.I.dvisor identified 60 similar cases where ILMN's stochastic oscillator exited the overbought zone, and of them led to successful outcomes. Odds of Success:

ILMN sees MACD Histogram crosses below signal line

ILMN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 01, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ILMN moved out of overbought territory on July 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ILMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ILMN broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on ILMN as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ILMN moved above its 50-day moving average on August 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 175 cases where ILMN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ILMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.959) is normal, around the industry mean (9.991). P/E Ratio (12.568) is within average values for comparable stocks, (135.399). Projected Growth (PEG Ratio) (0.617) is also within normal values, averaging (1.767). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.674) is also within normal values, averaging (8.776).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ILMN showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of integrated systems for the analysis of genetic variation and function

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5200 Illumina Way
Phone
+1 858 202-4500
Employees
10670
Web
https://www.illumina.com